ArrowMark Colorado Holdings’s Inhibrx INBX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.36M	Hold	35,176	–	–	0.06%	214
2025 Q4	$2.78M	Hold	35,176	–	–	0.06%	223
2025 Q3	$1.18M	Sell	35,176 -1,030	-3%	-$25.4K	0.02%	248
2025 Q2	$517K	Sell	36,206 -103,476	-74%	-$1.34M	0.01%	271
2025 Q1	$1.95M	Sell	139,682 -21,217	-13%	-$288K	0.03%	229
2024 Q4	$2.48M	Buy	160,899 +3,852	+2%	+$58.7K	0.03%	226
2024 Q3	$2.46M	Buy	157,047 +4,888	+3%	+$68.7K	0.03%	221
2024 Q2	$2.16M	Buy	+152,159	New	+$2.38M	0.03%	238

Other funds holding INBX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ArrowMark Colorado Holdings's INBX Position: Q1 2026 in Review

ArrowMark Colorado Holdings held its Inhibrx (INBX) position steady in Q1 2026 at 35,176 shares worth $2.36M. The position accounts for 0.06% of the portfolio, ranked #214.

ArrowMark Colorado Holdings first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.78M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

ArrowMark Colorado Holdings held 35,176 shares of Inhibrx worth $2.36M as of Q1 2026.
ArrowMark Colorado Holdings left its Inhibrx share count unchanged in Q1 2026.
Inhibrx made up 0.06% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #214 holding.
ArrowMark Colorado Holdings first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
ArrowMark Colorado Holdings's Inhibrx position peaked at $2.78M in Q4 2025.
135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.